Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSWy 14643 is an agonist of peroxisome proliferator-activated receptor α (PPARα).1 It selectively transactivates PPARα over PPARγ in a reporter assay using CV-1 mouse fibroblasts when used at a concentration of 100 µM. Wy 14643 (2 mg/kg) decreases distal colon protein levels of IFN-γ, TNF-α, IL-1β, and IL-6 in a mouse model of experimental colitis induced by dextran sulfate sodium (DSS; Item No. 23250).2 Wy 14643 (0.1% w/w in the diet) reduces hepatic triglycerides, leukocyte recruitment, and fibrosis in a mouse model of methionine- and choline-deficient diet-induced steatohepatitis.3
WARNING This product is not for human or veterinary use.
1. Peroxisome proliferator-
2. PPARα contributes to colonic protection in mice with DSS-
3. Administration of the potent PPARα agonist, Wy-
Inhibition of hepatic oxalate overproduction ameliorates metabolic dysfunction-
Cyclin D1 represses peroxisome proliferator-
Cyclic stretch facilitates myogenesis in C2C12 myoblasts and rescues thiazolidinedione-
Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-
Ankaflavin regulates adipocyte function and attenuates hyperglycemia caused by high-